Drug Shortage Report for FOLIC ACID INJECTION, USP
Report ID | 107559 |
Drug Identification Number | 02139480 |
Brand name | FOLIC ACID INJECTION |
Common or Proper name | Folic Acid Injection |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | FOLIC ACID |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
Packaging size | 5mg/mL, MD Vial, 10mL |
ATC code | B03BB |
ATC description | VITAMIN B12 AND FOLIC ACID |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-02-03 |
Estimated end date | Unknown |
Actual end date | 2020-04-09 |
Shortage status | Resolved |
Updated date | 2021-01-26 |
Company comments | Fresenius Kabi Canada Ltd. regrets to advise that due to a production delay, we will be placing our Folic Acid Injection 5mg/mL, 10mL vials on reduced allocation. Contract customers will be allocated 50% of their historical average monthly volumes, effective today, February 3, 2020. UPDATE Allocations Increased to 150% |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-03-02 | English | Compare |
v2 | 2020-03-02 | French | Compare |
v3 | 2021-01-26 | English | Compare |
v4 | 2021-01-26 | French | Compare |
Showing 1 to 4 of 4